Skip to content

Prospective Trial of Autologous Platelet Rich Plasma in Aortic Surgery

Prospective Randomized Trial of Autologous Platelet Rich Plasma in Reducing Allogeneic Transfusions During Aortic Surgery Under Deep Hypothermic Circulatory Arrest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02513862
Enrollment
80
Registered
2015-08-03
Start date
2015-05-31
Completion date
2016-10-31
Last updated
2016-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C.Surgical Procedure; Cardiac

Keywords

autologous platelet rich plasma, deep hypothermic circulatory arrest, transfusion

Brief summary

The purpose of this study is to determine whether autologous platelet rich plasma (APRP)is effective in reducing allogeneic blood transfusions during aortic surgery using deep hypothermic circulatory arrest.

Interventions

DEVICEAutologous Platelet-Rich Plasma Harvest Technique

15 to 20 mL/kg of whole blood is collected before the administration of heparin from a large-bore central venous access,and is separated into red blood cells component and autologous platelet-rich plasma component by an autologous transfusion system(Sorin Group Electa Essential; Sorin Group Italia, Milan, Italy).

Sponsors

Hongwen Ji
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing elective or emergency aortic surgery using deep hypothermic circulatory arrest、 * preoperative platelet counts\>150000000000/L、 * preoperative hematocrit\>33%、 * without recent anticoagulants less than 5 days

Exclusion criteria

* preoperative coagulation disorder * severe renal and liver dysfunction * preoperative hemodynamic instability

Design outcomes

Primary

MeasureTime frame
total perioperative allogenic transfusions of platelet and fresh frozen plasmaon the 7th day postoperatively

Secondary

MeasureTime frame
postoperative blood losson the 7th day postoperatively
rate of reexploration for bleedingon the 7th day postoperatively

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026